Discovery and Preclinical Evaluation of Anti-miR-17 Oligonucleotide RGLS4326 for the Treatment of Polycystic Kidney Disease
Nature Communications - United Kingdom
doi 10.1038/s41467-019-11918-y
Full Text
Open PDFAbstract
Available in full text
Date
September 12, 2019
Authors
Publisher
Springer Science and Business Media LLC